Solero Generator PG, Item No. H78712740000, Catalog No. 12740000
FDA Device Recall #Z-2439-2021 — Class II — July 20, 2021
Recall Summary
| Recall Number | Z-2439-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 20, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Angiodynamics, Inc. |
| Location | Queensbury, NY |
| Product Type | Devices |
| Quantity | 65 OUS |
Product Description
Solero Generator PG, Item No. H78712740000, Catalog No. 12740000
Reason for Recall
Specific serial numbers of the Solero MTA Generator require servicing to upgrade the software to help reduce the incidence of Error 0001, which can occur during system start-up.
Distribution Pattern
Domestic distribution Nationwide. Foreign distribution worldwide.
Lot / Code Information
Serial Nos. QBY0002623 QBY0002629 QBY0002857 QBY0002830 QBY0002843 QBY0002431 QBY0002715 QBY0002717 QBY0002731 QBY0002732 QBY0002744 QBY0002745 QBY0002363 QBY0002631 QBY0002834 QBY0001999 QBY0002000 QBY0002303 QBY0002353 QBY0002368 QBY0002432 QBY0002575 QBY0002653 QBY0002782 QBY0002783 QBY0002784 QBY0002004 QBY0002346 QBY0002576 QBY0002655 QBY0002680 QBY0002694 QBY0002709 QBY0002712 QBY0002791 QBY0002794 QBY0001991 QBY0001996 QBY0002036 QBY0002058 QBY0002703 QBY0002826 QBY0002833 QBY0002510 QBY0002624 QBY0002048 QBY0002012 QBY0002015 QBY0002481 QBY0002513 QBY0002531 QBY0002532 QBY0002812 QBY0002821 QBY0002738 QBY0002739 QBY0002564 QBY0002656 QBY0002657 QBY0002676 QBY0002014 QBY0002355 QBY0002563 QBY0002630 QBY0002743
Other Recalls from Angiodynamics, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1391-2025 | Class II | IsoLoc Short Profile Prostate Immobilization Tr... | Feb 4, 2025 |
| Z-0770-2025 | Class II | AURYON LASER SYSTEM 100-120 VAC. Model Number: ... | Nov 25, 2024 |
| Z-2454-2024 | Class II | SOFT-VU KUMPE 5F X 65CM -Used for patients in n... | Jun 18, 2024 |
| Z-2453-2024 | Class II | SOFT-VU KUMPE 5F X 40CM -Used for patients in n... | Jun 18, 2024 |
| Z-2267-2024 | Class II | IsoLoc Prostate Immobilization Treatment Balloo... | May 21, 2024 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.